Hydrogen Therapy Clears Psoriasis Skin and Joint Pain in 3 Patients
- Authors
- TORU ISHIBASHI, MIKI ICHIKAWA, BUNPEI SATO, SHINJI SHIBATA, YUICHI HARA, YUJI NARITOMI, KEN OKAZAKI, YASUHARU NAKASHIMA, YUKIHIDE IWAMOTO, SAMON KOYANAGI, HIROSHI HARA, TETSUHIKO NAGAO
- Journal
- Molecular Medicine Reports
- Year
- 2015
- DOI
- 10.3892/mmr.2015.3707
- Study Type
- Human
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- Japan
- Health Condition
- Psoriasis
- Body System
- Integumentary
TL;DR
Hydrogen gas treatments reduced skin inflammation and improved symptoms in three patients with psoriasis.
Key Finding
Three patients with psoriasis-associated arthritis showed improvements in disease severity scores and skin lesion severity after receiving molecular hydrogen through multiple delivery methods, with some patients also showing reduced levels of inflammatory markers.
Summary
This study followed three patients with psoriasis (a chronic inflammatory skin disease) who were treated with molecular hydrogen using three different methods: infusions of hydrogen-containing saline, inhalation of hydrogen gas, and drinking water with high levels of dissolved hydrogen. The researchers measured disease severity using standard scoring systems and tracked inflammatory markers in the blood. All three patients showed improvements in skin lesions and joint symptoms, and some showed decreases in inflammatory proteins associated with psoriasis.
Practical Takeaway
This case report provides early evidence that hydrogen water and other hydrogen delivery methods may help reduce psoriasis symptoms and inflammation. However, this study involved only three patients with no control group, so much larger and more rigorous trials are needed before any conclusions can be drawn about whether hydrogen water would help psoriasis patients more broadly. Anyone with psoriasis should continue their current medical treatment and consult their doctor before trying hydrogen water as a supplement.
Abstract (excerpt)
Psoriasis, a chronic inflammatory skin disease, is caused by infiltrating lymphocytes and associated cytokines, including tumor necrosis factor (TNF)α, interleukin (IL)-6, and IL-17. Effective treatments, including pathogenesis-based biological agents against psoriasis, are currently under…